AnaBios

AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies, including superior quality human tissue samples and functional assays focused, as well as human primary cells through its subsidiary Cell Systems.

InSphero

InSphero is the pioneer of industrial-grade, 3D-microtissue-based assay solutions and scaffold-free 3D organ-on-a-chip technology. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and immuno oncology.

Hesperos Inc.

Hesperos is accelerating drug discovery by providing safety and efficacy testing services using its Human-on-a-Chip, microphysiological system. This breakthrough technology enables unprecedented preclinical insight bringing better therapies to patients faster without the need for animal testing.

TissUse

TissUse is a Berlin, Germany-based, biotechnology company who has developed a unique HUMIMIC Multi-Organ-Chip platform for advanced toxicity testing and cutting-edge disease modelling.

MIMETAS

Mimetas develops high-throughput healthy and diseased organ-on-a-chip models in the OrganoPlateĀ®, a screening-compatible microfluidics platform that supports the recreation of native tissue structures, and their interaction with compounds, signaling factors, disease triggers, and co-cultured cell types.